Protocol Summaries: azelastine hydrochloride

Protocol Summaries for azelastine hydrochloride
GSK
Study ID
Phase Title Status
E-RHS00176 phase 1 A pharmacokinetic study comparing two azelastine hydrochloride nasal formulations in a single dose design Recruiting

Filter list by: